The Digital Solution Empowering Gastroenterology Teams

From diagnosis to long-term follow-up, Resilience Gastroenterology helps care teams deliver more personalized, proactive, and coordinated care — to the right patient, at the right time.

Request a demo

Proven Clinical, Operational, and Economic Benefits

Backed by scientific evidence for chronic Inflammatory Bowel Disease (IBD) with measurable outcomes across clinical care, operational efficiency, and economic impacts

Clinicial Benefits

From reactive to proactive monitoring: improve patients’ tolerance to treatment, adherence, and quality of life.

+70%

of early-detected events allow treatment adjustments without an ER visit (1)

80%

of patients feel better supported thanks to remote monitoring (2)

Operational Benefits

From fragmented monitoring to seamless organization: simplify daily workflows for care teams and improve care coordination

+30%

medical time saved with structured alerts (1)

- 40%

number of consultation (2)

Fewer

and shorter phone calls

Economic Benefits

From complex processes to a streamlined approach: improve operational efficiency and optimize resource allocation

Optimized

Ressource allocation

Scalable

Accross care teams and facilities

Built for Every Stakeholder in Gastroenterology Care

Addressing everyone involved in the patient journey — from clinicians to patients themselves.

We aim to Support multiple Gastroenterology Pathways

We currently support the Inflammatory Bowel Disease (IBD) pathway with specialized monitoring and management solutions, and we are actively developing additional pathways to be launched soon.

Request a Live Demo

GC-102
Ongoing Multicenter Randomized Trial

We are conducting the GC-102 study in order to generate robust evidence on the budgetary, clinical, and organizational impact of the Resilience Gastroenterology remote monitoring solution, and to assess the level of engagement and adherence among both patients and healthcare professionals.

18 centers

involved in the study

116 patients

enrolled & treated forUlcerative colitis or Crohn’s Disease

Learn more about GC-102 clinical trial

Our Partners

Our proven track record speaks to the trust and impact we've built in the oncology community.

Become a partner

What our Users Say

Real feedback from healthcare professionals and patients using our solutions daily.

90%*

of clinicians see our solution as a game-changer for identifying non-responders

"It seems like an essential tool for the patient, enabling them to better appropriate their disease and their follow-up, and for the HCPs. We see a relational benefit in this tripartite journey and a time saving, at a time of medical shortage and resources in the hospital, which is golden for us."

Dr. Ludovic Caillo - Gastroenterologist and Hepatologist

CHU Nîmes

72%*

of nurses report improved patient communication

"RPM is not just a matter of technology: it’s a whole other way of caring. More proactive for us, as nurses, more human too, and more adapted to the reality of patients with IBD."

Audrey Borel - Infirmière en hépato-gastro-entérologie

CHU Nîmes

96%*

of patients comply with both symptom questionnaires and fecal calprotectin testing

"This application helps in the daily life because it addresses the whole daily life, not just the disease. It allows you to tame this disease and have solutions to adapt your daily life to live with it as best as possible."

Cécile - Patient

Remotely monitored

*Satisfaction survey conducted by Resilience among caregivers & patients using the solution - December 2024.